Cardinal Health’s acquisition of Advanced Diabetes Supply Group hasn’t closed yet, but company officials said on a conference call to discuss second quarter financial results that ...
In many respects, Cardinal Christoph Schönborn and Cardinal Timothy Dolan have traveled similar paths to the most powerful ...
Mizuho Securities analyst Steven Valiquette has reiterated their bullish stance on CAH stock, giving a Buy rating yesterday.Invest with ...
Citi analyst Daniel Grosslight increased the price target for Cardinal Health (NYSE:CAH) shares to $130 from the previous ...
Cardinal Health warned Thursday that if President Donald Trump follows through with threatened tariffs next month, higher ...
Despite his disappointment, Cardinal Dolan expressed hope that Vance’s comments were uncharacteristic and not reflective of ...
Only one more half stands between Stanford and the win they were favored to collect coming into this evening. They have ...
6d
The once-powerful archbishop of Peruvian capital Lima and the first-ever cardinal of Opus Dei has acknowledged that the ...
Charles Rhyee, an analyst from TD Cowen, maintained the Buy rating on Cardinal Health (CAH – Research Report). The associated price target was ...
The Cardinal STEM Academy program with Green Valley Elementary went to East Tennessee university this past Saturday and ...
The Peruvian cardinal revealed that in August 2018, the Holy See informally informed him of the existence of a complaint ...
Drug distributor Cardinal Health on Thursday raised its fiscal 2025 adjusted profit forecast as strong demand for costly specialty medicines and branded drugs drove sales at its pharmaceuticals unit.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback